The analysis at baseline conditions revealed a general downregulation of phosphorylated signaling proteins in MS across all peripheral cellular components, in particular p38MAPK, with the exception of Akt and Cbl, which were found upregulated in MS patients. The gene discussed is CBL; the disease is myeloid sarcoma.